illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. Medios
Company logo

Medios | Sustainability Performance

https://www.medios.ag

The company provides logistical and distribution services, particularly for the healthcare sector. It focuses on improving the supply chain efficiency for pharmaceuticals.

2016

Germany

501 - 1,000 employees

Pharmaceuticals

$1B - 10B in revenue

$10M - 25M in profitability

Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.

Sustainability Ranking & Industry Benchmark

#1933
Overallⓘ
#103
in Germanyⓘ
#49
in Pharmaceuticalsⓘ

Sustainability Maturity

ⓘ
​​0123456789​​%

Sustainability Intent

ⓘ

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

163 out of 292

Overview
Environmental
Energy consumption
Governance
Targets
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
STADA

Germany, Health Care, Pharmaceuticals


Company logo
Dermapharm

Germany, Health Care, Pharmaceuticals


Company logo
Merck

Germany, Health Care, Pharmaceuticals

Renewable energy ⓘProportion of the company's total electricity consumption sourced from renewable sources, expressed as a percentage.
41%2023
Laggard
Market cap ⓘTotal market value of the company's outstanding shares, calculated by multiplying the share price by the number of shares outstanding.
327.0M$, 2026▼10.7% YoY
Revenue ⓘTotal revenue reported in the company's financial statements for the specified reporting year, reflecting income generated from primary business activities. Expressed in millions of USD.
1.9B$, 2024▼5.3% YoY

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Medios faced scrutiny over compliance with pharmaceutical distribution regulations in Germany following rapid growth through acquisitions.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees

ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.

Total sustainability employees

2-3

ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.

    Available in
    Scale package

    Access
  • Email

  • Email